Related Experiment Video
Updated: Jun 30, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Vitamin K deficiency bleeding (VKDB) in early infancy
1The Centre for Haemostasis and Thrombosis, St. Thomas' Hospital, Westminster Bridge Road, London, UK. martin.shearer@gstt.nhs.uk
Vitamin K deficiency bleeding (VKDB) is a serious infant disorder. Parenteral vitamin K at birth is the most effective prevention, particularly for late-onset cases.
Area of Science:
- Pediatrics
- Neonatology
- Hematology
Background:
- Vitamin K deficiency bleeding (VKDB) is a rare but severe bleeding disorder in infants.
- Infants are born with low vitamin K stores, and breast milk has low concentrations, increasing risk.
- Classical VKDB occurs in the first week, while late VKDB (3-8 weeks) often involves intracranial hemorrhage due to malabsorption.
Purpose of the Study:
- To review the epidemiology, diagnosis, and prevention of Vitamin K deficiency bleeding (VKDB).
- To highlight the effectiveness of different vitamin K prophylaxis strategies.
Main Methods:
- Review of existing literature on VKDB incidence, risk factors, and prevention.
- Discussion of diagnostic methods, including PIVKA-II measurements.
- Analysis of the efficacy of oral versus parenteral vitamin K prophylaxis.
Main Results:
- Late VKDB incidence is higher in Southeast Asia compared to Europe without prophylaxis.
- Parenteral vitamin K offers the best protection against VKDB.
- Oral prophylaxis efficacy varies with dose and frequency, with some infants with undetected liver disease remaining at risk.
Conclusions:
- Vitamin K deficiency bleeding (VKDB) is largely preventable with appropriate vitamin K administration.
- Parenteral vitamin K prophylaxis is superior to oral routes for comprehensive protection.
- Targeted surveillance of high-risk infants is a potential strategy to improve prophylaxis efficacy.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Vitamins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Venous Thrombosis III: Interprofessional Care
